Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
Clinical Chemistry 1997, May, 43, 5
-
- 2,99 €
-
- 2,99 €
Beschreibung des Verlags
Panel II of the 1996 Clinical Chemistry Forum was a discussion initiated by brief formal presentations from Rosemary Bakes-Martin of the US Centers for Disease Control and Prevention (CDC), Cornelia Rooks of the US Food and Drug Administration (FDA), William Hamlin of the College of American Pathologists (CAP), Nathan Gochman of Beckman Instruments, and David Witte of this Forum Committee. Initial Presentations
Mehr ähnliche Bücher
Quality: The Next Six Months (Clinical Chemistry Forum)
1997
Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial)
1999
Quality Assurance
2013
Laboratory Medicine: Challenges and Opportunities (Opinion)
2007
Pharmaceutical Analysis for Small Molecules
2017
Pharmaceutical Quality by Design
2018
Mehr Bücher von Clinical Chemistry
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998